 Diabetes-induced alterations atrial natriuretic peptide gene expression Wistar-Kyoto hypertensive rats effects streptozotocin-induced diabetes atrial natriuretic peptide ANP synthesis hemodynamic parameters blood volume histopathology reversibility effects insulin therapy Wistar-Kyoto WKY rats hypertensive rats SHRs biatrial ANP messenger RNA mRNA levels diabetic WKY rats age-matched WKY rats weeks onset diabetes ventricular ANP mRNA levels increases left ventricles right ventricles weeks diabetic SHRs left atrial ANP mRNA levels age-matched SHRs weeks diabetes ventricular ANP mRNA levels increases left right ventricles weeks proportion changes cardiac ANP synthesis biventricular end-diastolic pressures weeks diabetic WKY rats weeks diabetic SHRs blood volume weeks diabetic WKY rats diabetic SHRs experimental period left ventricular peak dP/dt diabetic SHRs whereas diabetic WKY rats depression weeks diabetes Histopathological studies diabetic changes ANP synthesis hemodynamic parameters cardiomyopathic histological changes Cardiac ANP synthesis diabetic rats levels insulin therapy normalization hemodynamic parameters present study ANP synthesis streptozotocin-induced diabetic rat normal rat combination diabetes hypertension effect cardiac ANP synthesis elevation intraventricular filling pressure observable cardiomyopathic histopathological alterations augmented ANP synthesis reversibility insulin therapy streptozotocin-induced alterations cardiac ANP synthesis hemodynamics insulin-deficient diabetes mellitus cardiac toxicity streptozotocin